National ALS Registry Seeks Participants to Unlock Disease Mysteries

The National ALS Registry, a CDC program, encourages people with ALS to enroll and complete risk factor surveys to aid research into causes and treatments, highlighting the urgent need for data to combat the disease that affects over 5,000 new Americans annually.

June 11, 2026
National ALS Registry Seeks Participants to Unlock Disease Mysteries

The U.S. National ALS Registry is calling on individuals living with amyotrophic lateral sclerosis (ALS) to participate in its data collection efforts, aiming to shed light on a disease that remains poorly understood. Every year, more than 5,000 Americans are diagnosed with ALS, a progressive neurodegenerative disease that leads to muscle weakness and paralysis. Despite its devastating impact, the causes of most cases remain unknown, a gap the registry seeks to fill.

"The National ALS Registry is a program of, by and for those living with ALS," said Dr. Paul Mehta, principal investigator of the Registry. "The program collects, manages and analyzes data about people with ALS in the United States. It includes data and information provided by individuals who choose to register and complete the risk factor surveys." Launched in 2010, the registry has since funded over a dozen studies exploring potential risk factors, from occupational history to environmental exposures.

The registry's primary purpose is to gather information that can be used in the fight against ALS. The data helps estimate the number of new cases diagnosed each year, the total number of people living with ALS at any given time, and better understand who gets the disease and what factors affect it. Researchers use the data to look for disease pattern changes over time and identify common risk factors among patients. By enrolling, individuals with ALS can contribute to research that could improve care and potentially uncover causes.

Participation involves completing up to 18 risk factor surveys, covering topics such as occupational history and environmental exposures. These surveys help create a more complete picture of each person's ALS story. Anyone living with ALS can enroll by visiting cdc.gov/als. The registry emphasizes that joining and taking the surveys can help future generations by enhancing ALS data and supporting research efforts.

The implications of this announcement are significant. With no known cure for ALS and limited understanding of its causes, the registry represents a critical tool for advancing research. The data collected could lead to breakthroughs in identifying risk factors, improving patient care, and eventually finding a cure. For the thousands of Americans diagnosed each year, participation in the registry offers a way to contribute to science and potentially accelerate progress against the disease.